AstraZeneca buys Pearl for $1.15bn

Home › AstraZeneca buys Pearl for $1.15bn

AstraZeneca, the UK's second-largest drugs company, is to buy Pearl Therapeutics, a US lung drug specialist, in a deal worth up to $1.15bn.

16.11	Record numbers seek help with water bills
16.11	Billions at stake in court battle over North Sea oil
15.11	China megaport opens up Latin America as wary US looks on
15.11	China megaport opens up Latin America as wary US looks on
15.11	Post Office scandal: Who knew what and when?
15.11	Mortgage costs rise despite interest rate cut
15.11	Health stocks hit after Trump taps RFK Jr for top job
15.11	X users jump to Bluesky - but what is it and who owns it?
Consumer Goods and Services »

je.st